Our focus instead is the evaluation of the potential adjunct prognostic significance of tumor CEA, Ki-67, and pathologic subtype, and to determine how to use these factors to refine accuracy of prognosis in patients who have surgery for TNM stage I pulmonary adenocarcinoma. The gene discussed is MKI67; the disease is neoplasm.